GEODE CAPITAL MANAGEMENT, LLC - NEPHROS INC ownership

NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 18 filers reported holding NEPHROS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of NEPHROS INC
ValueSharesWeighting
Q3 2023$106,228
-11.4%
71,037
-8.2%
0.00%
Q2 2023$119,883
+888.4%
77,344
+595.0%
0.00%
Q1 2023$12,129
+100975.0%
11,128
-2.0%
0.00%
Q4 2022$12
-99.9%
11,3590.0%0.00%
Q3 2022$10,000
-41.2%
11,3590.0%0.00%
Q2 2022$17,000
-61.4%
11,359
+11.5%
0.00%
Q1 2022$44,00010,1920.00%
Other shareholders
NEPHROS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Parkman Healthcare Partners LLC 199,724$1,987,0000.57%
INGALLS & SNYDER LLC 134,539$1,339,0000.07%
ELKHORN PARTNERS LIMITED PARTNERSHIP 5,908$59,0000.03%
B. Riley Wealth Advisors, Inc. 14,254$142,0000.01%
HighTower Advisors, LLC 43,210$430,0000.00%
BLAIR WILLIAM & CO/IL 34,249$341,0000.00%
MILLENNIUM MANAGEMENT LLC 22,501$224,0000.00%
DEUTSCHE BANK AG\ 200$1,0000.00%
BlackRock Inc. 2,562$25,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 367$4,0000.00%
View complete list of NEPHROS INC shareholders